LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to slow advanced breast cancer progression
Disease control OngoingThis study tests whether adding the drug giredestrant to the standard treatment Phesgo can help people with a certain type of advanced breast cancer (HER2-positive and estrogen receptor-positive) live longer without their cancer getting worse. About 922 participants who have not …
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
New hope for advanced breast cancer: drug combo aims to delay next treatment
Disease control OngoingThis study tests a combination of two drugs, capivasertib and fulvestrant, in people with a certain type of advanced breast cancer (HR+/HER2-) that has gotten worse after standard hormone therapy and a CDK4/6 inhibitor. The goal is to see how long it takes before patients need an…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 19, 2026 12:01 UTC